Table 1 Patient characteristics
Factor | Adeno | Small cell | Urothelial | Squamous | P-value |
|---|---|---|---|---|---|
Gender | |||||
Female | 6 (35%) | 3 (18%) | 18 (19%) | 15 (41%) | |
Male | 11 (65%) | 14 (82%) | 78 (81%) | 22 (59%) | 0.05a |
Age | |||||
Mean±s.d. | 59.9±12.0 | 66.2±12.8 | 71.8±10.7 | 69.1±8.5 | |
Median | 62 | 70 | 74 | 72 | <0.001b |
Range | 37–78 | 39–86 | 37–90 | 46–80 | |
LN status | |||||
Negative | 3 (18%) | 12 (71%) | 30 (31%) | 16 (43%) | |
Positive | 14 (82%) | 5 (29%) | 66 (69%) | 21 (57%) | 0.001a |
Pathologic T-stage | |||||
1 | — | — | 2 (2%) | — | |
2 | 2 (12%) | 11 (65%) | 23 (24%) | 16 (43%) | |
3 | 13 (76%) | 5 (29%) | 65 (68%) | 21 (57%) | |
4 | 2 (12%) | 1 (6%) | 6 (6%) | — | 0.002b |
PSMA | |||||
Negative | 15 (88%) | 14 (82%) | 93 (97%) | 37 (100%) | |
Positive | 2 (12%) | 3 (18%) | 3 (3%) | — | 0.03a |
